Vancomycin-resistant Enterococcus in liver transplant recipients: A dramatic improvement in outcomes with new anti-VRE antibiotics.

被引：0
|
作者：
Soule, JL
Olyaei, AJ
Busch, AMH
Schwartz, JM
Rosen, HR
Ham, JM
Orloff, SL
机构：
[1] Oregon Hlth Sci Univ, Dept Surg, Div Transplantat, Portland, OR 97201 USA
[2] Portland VA Med Ctr, Dept Surg, Div Transplantat, Portland, OR 97201 USA
[3] Oregon Hlth Sci Univ, Dept Med, Div Hepatol, Portland, OR 97201 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
737
引用
收藏
页码：358 / 359
页数：2
相关论文
共 50 条
  • [31] Characteristics and Outcomes of Vancomycin Resistant Enterococcus Bacteremia After Liver Transplant
    Odrobina, R.
    Kovacs, C.
    Butler, R.
    Koval, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 260 - 261
  • [32] Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients
    Patel, R
    Allen, SL
    Manahan, JM
    Wright, AJ
    Krom, RAF
    Wiesner, RH
    Persing, DH
    Cockerill, FR
    Thompson, RL
    LIVER TRANSPLANTATION, 2001, 7 (01) : 27 - 31
  • [33] Treatment and outcome of vancomycin-resistant enterococcal infection in liver transplant recipients with linezolid
    Linden, PK
    Kramer, DJ
    Birmingham, MC
    Kusne, S
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 278 - 278
  • [34] Incidence and outcome of vancomycin-resistant enterococcus infection in pediatric liver transplant patients.
    Cronin, DC
    Brady, L
    Mead, JM
    Siegel, C
    Yoshida, A
    Oswald, K
    Newell, KA
    Millis, JM
    TRANSPLANTATION, 1999, 67 (07) : S232 - S232
  • [35] Vancomycin-resistant enterococcus (VRE) colonization is associated with a high rate of bacteremia and early mortality in transplant/leukemia patients.
    Leis, Jose F.
    Newton, Abby
    Post, Mary T.
    Hayes-Lattin, Brandon M.
    Maziarz, Richard Thomas
    Taplitz, Randy A.
    BLOOD, 2006, 108 (11) : 421B - 421B
  • [36] Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci
    Burastero, Giulia
    Wey, Emmanuel Q.
    Guidetti, Veronica
    Cantergiani, Samuele
    Lo Porto, Davide
    Serra, Valentina
    Assirati, Giacomo
    Di Benedetto, Fabrizio
    Guaraldi, Giovanni
    Meschiari, Marianna
    Cervo, Adriana
    Dolci, Giovanni
    Mularoni, Alessandra
    Girardis, Massimo
    Mussini, Cristina
    Franceschini, Erica
    TRANSPLANTATION, 2024, 108 (09) : 352 - 352
  • [37] The direct and indirect effects of vancomycin-resistant enterococci colonization in liver transplant candidates and recipients
    Belga, Sara
    Chiang, Diana
    Kabbani, Dima
    Abraldes, Juan G.
    Cervera, Carlos
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (05) : 363 - 373
  • [38] Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant enterococcus faecium infections in liver transplant recipients; A reply to Lewis et al
    Jorgenson, Margaret R.
    Descourouez, Jillian L.
    Leverson, Glen E.
    Rose, Warren E.
    Smith, Jeannina A.
    Fernandez, Luis A.
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (06)
  • [39] Genomic confirmation of vancomycin-resistant Enterococcus transmission from deceased donor to liver transplant recipient
    Bashir, Ali
    Attie, Oliver
    Sullivan, Mitchell
    Sebra, Robert
    Singh, Kavindra V.
    Altman, Deena
    Pak, Theodore
    Dutta, Jayeeta
    Chacko, Kieran
    Webster, Elizabeth
    Lewis, Martha
    Hamula, Camille
    Delli Carpini, Kristin W.
    Murray, Barbara E.
    Kasarskis, Andrew
    van Bakel, Harm
    Huprikar, Shirish
    PLOS ONE, 2017, 12 (03):
  • [40] Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients: A reply to Jorgenson et al
    Lewis, Jessica D.
    Barros, Andrew J.
    Sifri, Costi D.
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (01)
12345